Questions and answers for biological medicinal products

New Approach Methodologies EU-IN Horizon Scanning Report

3-year rolling work plan for the Biosimilar Medicinal Products Working Party 2026-2028

Alzheimer’s disease EU-IN Horizon Scanning Report

3-year work plan for the Biologics Working Party (BWP) 2026-2028

Human medicines European public assessment report (EPAR): Aubagio, teriflunomide, Date of authorisation: 26/08/2013, Revision: 30, Status: Authorised

Development and manufacture of synthetic peptides - Scientific guideline

Guideline on the development and manufacture of synthetic peptides

Human medicines European public assessment report (EPAR): Eviplera, emtricitabine,rilpivirine,tenofovir disoproxil, Date of authorisation: 27/11/2011, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Abecma, idecabtagene vicleucel, Date of authorisation: 18/08/2021, Revision: 14, Status: Authorised